Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Launched by UNIVERSITY OF NEBRASKA · May 18, 2021
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how physical activity can help improve thinking and memory skills in older adults who have recently undergone a stem cell transplant for blood cancers like leukemia and lymphoma. Researchers believe that exercise can boost cognitive function, which is often affected by cancer treatments. The trial involves older adults aged 60 and older, who have had a stem cell transplant within the last 3-6 months. Participants will work with a care partner and engage in a specially designed physical activity program over several months, with the goal of enhancing their cognitive abilities and overall quality of life.
To be eligible, participants must be at least 60 years old, have been diagnosed with a blood cancer, and be able to read and speak English. There are no major health exclusions, but participants will need to be cleared for exercise by their doctors if they have certain heart or recent surgery conditions. Throughout the trial, participants can expect to take part in light to moderate exercise while receiving support and guidance from the research team. This study aims to not only help improve mental function but also to provide valuable insights into how physical activity can benefit older adults facing similar health challenges.
Gender
ALL
Eligibility criteria
- Arm 1:
- Inclusion Criteria for Participants:
- • age 60 years and older
- • have a diagnosis of hematological malignancy
- • have received autologous or allogeneic HCT within the prior 3-6 months
- • able to speak and read English
- • have provided written informed consent
- Exclusion Criteria for Participants:
- • there are no exclusion criteria
- Inclusion Criteria for Participants' Care-Partner:
- • age 19 years and older
- • able to speak and read English
- Exclusion Criteria for Participants' Care-Partner:
- • there are no exclusion criteria
- Inclusion Criteria for Transplant Team Member:
- • age 19 years and older
- • able to speak and read English
- Exclusion Criteria for Transplant Team Member:
- • there are no exclusion criteria
- Arms 2 and 3:
- Inclusion Criteria for Participants:
- • age 55 years and older
- • have a diagnosis of hematological malignancy
- • planned to receive an autologous or allogeneic HCT
- • able to walk 4 meters as part of the Short Physical Performance Battery (with or without assistance)
- • (In Arm 3 only): willingness to be randomized to either initiate the physical activity intervention pre-HCT or following Day 180 post-HCT, and to follow the protocol for the group to which they have been assigned
- • able to speak and read English
- • have provided written informed consent
- Exclusion Criteria for Participants:
- • development of chest pain, severe shortness of breath, or occurrence of other safety concerns during the physical performance measures (i.e. Short Physical Performance Battery)
- • is not cleared to participate in exercise by a physician
- Individuals with the following current conditions/diagnoses documented in medical history will be required to provide clearance for exercise from their cardiologist:
- • Myocardial infarctions in the past 3 months
- • Resting or unstable angina
- • Uncontrolled and/or serious arrhythmias
- • 3rd degree heart block
- • Acute congestive heart failure or ejection fraction \<30%
- • Clinically significant aortic stenosis
- Individuals with the following conditions/diagnoses will be required to provide clearance for exercise from their surgeon:
- • Hip fracture, hip or knee replacement, or spinal surgery in the past 3 months
- • other medical, psychiatric, or behavioral factors that in the judgement of the principal investigator may interfere with study participation or the ability to follow either the intervention or the active control condition
- * (In Arm 3 for those who agree to the voluntary measures of blood, saliva and MRI, there are additional exclusions to avoid conditions that may confound study outcomes):
- • history of residual brain abnormalities from prior severe traumatic brain injury (e.g. encephalomalacia) or other significant abnormalities documented on a recent brain MRI (e.g. brain cancer, large vessel strokes, residual subdural hematoma)
- • history of major stroke with obvious residual deficits
- • history of relapsing and remitting Multiple Sclerosis
- • active moderate to severe psychiatric symptoms due to primary psychiatric disorder
- Inclusion Criteria for Participants' Care-Partner:
- • age 19 years and older
- • able to speak and read English
- • able to walk 4 meters as part of the Short Physical Performance Battery (with or without assistance)
- • have no medical contraindications for participating in light to moderate-intensity physical activity per PI review of medical history as reported on the care-partner medical history form
- Exclusion Criteria for Participants' Care-Partner:
- • development of chest pain, severe shortness of breath, or occurrence of other safety concerns during the physical performance measures (i.e. Short Physical Performance Battery)
- • is not cleared to participate in exercise by a physician
- Individuals with the following current conditions/diagnoses documented in medical history will be required to provide clearance for exercise from their cardiologist:
- • Myocardial infarctions in the past 3 months
- • Resting or unstable angina
- • Uncontrolled and/or serious arrhythmias
- • 3rd degree heart block
- • Acute congestive heart failure or ejection fraction \<30%
- • Clinically significant aortic stenosis
- Individuals with the following conditions/diagnoses will be required to provide clearance for exercise from their surgeon:
- • o Hip fracture, hip or knee replacement, or spinal surgery in the past 3 months
- • other medical, psychiatric, or behavioral factors that in the judgement of the principal investigator may interfere with study participation or the ability to follow either the intervention or the active control condition
- Inclusion Criteria for Transplant Team Member:
- • age 19 years and older
- • able to speak and read English
- Exclusion Criteria for Transplant Team Member:
- • there are no exclusion criteria
About University Of Nebraska
The University of Nebraska is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong commitment to improving patient outcomes and fostering scientific discovery, the university collaborates with various healthcare professionals and researchers to conduct rigorous clinical studies across diverse medical fields. The institution prioritizes ethical standards and patient safety while striving to translate research findings into practical solutions that enhance medical practices and contribute to the overall well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Omaha, Nebraska, United States
Patients applied
Trial Officials
Thuy Koll, MD
Principal Investigator
University of Nebraska
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials